Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications
Cells · 24.01.2025 · 14 (3) · 178
DOI: 10.3390/cells14030178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 24.01.2025. Verfasst von Anirudh Nayak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Master of Science in Biomedical Sciences Program, California Health Sciences University, Clovis, CA 93612, USA. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Wnt Signaling Pathway, Molecular Targeted Therapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The Wnt signaling pathway is critical in the onset and progression of gastrointestinal (GI) cancers. Anomalies in this pathway, often stemming from mutations in critical components such as adenomatous polyposis coli (APC) or β-catenin, lead to uncontrolled cell proliferation and survival. In the case of colorectal cancer, dysregulation of the Wnt pathway drives tumor initiation and growth. Similarly, aberrant Wnt signaling contributes to tumor development, metastasis, and resistance to therapy in other GI cancers, such as gastric, pancreatic, and hepatocellular carcinomas. Targeting the Wnt pathway or its downstream effectors has emerged as a promising therapeutic strategy for combating these highly aggressive GI malignancies. Here, we review the dysregulation of the Wnt signaling pathway in the pathogenesis of GI cancers and further explore the therapeutic potential of targeting the various components of the Wnt pathway. Furthermore, we summarize and integrate the preclinical evidence supporting the therapeutic efficacy of potent Wnt pathway inhibitors with completed and ongoing clinical trials in GI cancers. Additionally, we discuss the challenges of Wnt pathway-targeted therapies in GI cancers to overcome these concerns for effective clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Master of Science in Biomedical Sciences Program, California Health Sciences University, Clovis, CA 93612, USA.
ORCID-Profile: Anitha Kota Shenoy
Zitieren
APA
Nayak, A., Streiff, H., Gonzalez, I., Adekoya, O. O., Silva, I., & Shenoy, A. K. (2025). Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications. Cells, 14(3), 178. https://doi.org/10.3390/cells14030178
Vancouver
Nayak A, Streiff H, Gonzalez I, Adekoya OO, Silva I, Shenoy AK. Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications. Cells. 2025;14(3):178. doi:10.3390/cells14030178
BibTeX
@article{Nayak2025,
author = {Nayak, Anirudh and Streiff, Hannah and Gonzalez, Ivan and Adekoya, Oluwabomi Oluwatomi and Silva, Itzcoatl and Shenoy, Anitha Kota},
title = {Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications},
journal = {Cells},
year = {2025},
volume = {14},
number = {3},
pages = {178},
doi = {10.3390/cells14030178}
}
EUVIMED